An official website of the United States government
TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2008
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Arizona | 140 | 32.1 | 8.0 | (16.4 – 47.8) | 146 | 32.2 | 7.9 | (16.7 – 47.7) |
| California | 396 | 32.2 | 3.3 | (25.7 – 38.7) | 425 | 32.0 | 3.2 | (25.7 – 38.3) |
| Connecticut | 233 | 32.8 | 4.5 | (24.0 – 41.6) | 246 | 31.2 | 4.2 | (23.0 – 39.4) |
| District of Columbia | 139 | 37.3 | 5.0 | (27.5 – 47.1) | 151 | 35.1 | 4.8 | (25.7 – 44.5) |
| Florida | 283 | 27.8 | 5.0 | (18.0 – 37.6) | 318 | 27.7 | 4.8 | (18.3 – 37.1) |
| Georgia | 198 | 26.8 | 4.6 | (17.8 – 35.8) | 214 | 24.5 | 4.1 | (16.5 – 32.5) |
| Hawaii | 299 | 34.7 | 4.1 | (26.7 – 42.7) | 307 | 35.1 | 4.1 | (27.1 – 43.1) |
| Illinois | 220 | 40.1 | 4.3 | (31.7 – 48.5) | 241 | 35.0 | 4.0 | (27.2 – 42.8) |
| Indiana | 230 | 35.8 | 4.3 | (27.4 – 44.2) | 248 | 34.8 | 4.2 | (26.6 – 43.0) |
| Iowa | 233 | 31.9 | 4.3 | (23.5 – 40.3) | 241 | 32.2 | 4.3 | (23.8 – 40.6) |
| Kansas | 399 | 31.5 | 3.0 | (25.6 – 37.4) | 417 | 30.5 | 2.9 | (24.8 – 36.2) |
| Maine | 376 | 44.6 | 3.6 | (37.5 – 51.7) | 405 | 42.5 | 3.4 | (35.8 – 49.2) |
| Maryland | 319 | 30.0 | 3.6 | (22.9 – 37.1) | 336 | 29.3 | 3.3 | (22.8 – 35.8) |
| Massachusetts | 295 | 41.4 | 4.9 | (31.8 – 51.0) | 316 | 37.5 | 4.6 | (28.5 – 46.5) |
| Michigan | 496 | 35.9 | 3.7 | (28.6 – 43.2) | 539 | 32.3 | 3.5 | (25.4 – 39.2) |
| Missouri | 234 | 46.8 | 6.1 | (34.8 – 58.8) | 257 | 42.6 | 5.7 | (31.4 – 53.8) |
| Montana | 226 | 41.0 | 4.8 | (31.6 – 50.4) | 231 | 39.2 | 4.8 | (29.8 – 48.6) |
| Nebraska | 541 | 35.9 | 4.0 | (28.1 – 43.7) | 572 | 34.2 | 3.8 | (26.8 – 41.6) |
| Nevada | 180 | 28.8 | 5.4 | (18.2 – 39.4) | 197 | 24.8 | 4.8 | (15.4 – 34.2) |
| New Hampshire | 316 | 35.1 | 3.4 | (28.4 – 41.8) | 344 | 33.8 | 3.2 | (27.5 – 40.1) |
| New Jersey | 294 | 29.0 | 3.9 | (21.4 – 36.6) | 326 | 28.5 | 3.7 | (21.2 – 35.8) |
| New Mexico | 266 | 41.7 | 5.2 | (31.5 – 51.9) | 282 | 41.0 | 5.0 | (31.2 – 50.8) |
| New York | 298 | 35.8 | 4.0 | (28.0 – 43.6) | 339 | 30.5 | 3.6 | (23.4 – 37.6) |
| North Dakota | 197 | 45.4 | 5.2 | (35.2 – 55.6) | 204 | 46.7 | 5.0 | (36.9 – 56.5) |
| Ohio | 330 | 38.6 | 5.3 | (28.2 – 49.0) | 364 | 36.2 | 4.9 | (26.6 – 45.8) |
| Oklahoma | 270 | 26.9 | 3.2 | (20.6 – 33.2) | 287 | 26.0 | 3.1 | (19.9 – 32.1) |
| Oregon | 265 | 39.1 | 4.0 | (31.3 – 46.9) | 289 | 34.0 | 3.9 | (26.4 – 41.6) |
| Rhode Island | 266 | 32.5 | 4.2 | (24.3 – 40.7) | 291 | 31.4 | 4.0 | (23.6 – 39.2) |
| Texas | 368 | 29.8 | 3.9 | (22.2 – 37.4) | 398 | 25.8 | 3.6 | (18.7 – 32.9) |
| Utah | 221 | 29.5 | 3.9 | (21.9 – 37.1) | 235 | 29.8 | 3.8 | (22.4 – 37.2) |
| Vermont | 376 | 37.6 | 3.0 | (31.7 – 43.5) | 416 | 33.9 | 2.8 | (28.4 – 39.4) |
| Virginia | 206 | 25.8 | 4.7 | (16.6 – 35.0) | 219 | 26.0 | 4.6 | (17.0 – 35.0) |
| Washington | 488 | 37.5 | 3.4 | (30.8 – 44.2) | 542 | 33.8 | 3.0 | (27.9 – 39.7) |
| West Virginia | 230 | 32.1 | 4.1 | (24.1 – 40.1) | 241 | 31.6 | 3.9 | (24.0 – 39.2) |
| Wisconsin | 229 | 30.2 | 4.3 | (21.8 – 38.6) | 237 | 27.5 | 4.2 | (19.3 – 35.7) |
| 35 areas total | 10,057 | 33.5 | 1.0 | (31.5 – 35.5) | 10,821 | 31.3 | 1.0 | (29.3 – 33.3) |
| Median | 34.7 | 32.2 | ||||||
| Range | 25.8-46.8 | 24.5-46.7 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Sample size excludes “DK/Refused”
§ Standard error
† Confidence interval